ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Aerovate Therapeutics Inc

Aerovate Therapeutics Inc (AVTE)

2.46
-0.04
( -1.60% )
Updated: 11:02:12

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -15.85M-17.64M-20.34M-21.37M-22.07M-24.62M-26.17M-17.41M
Pre Tax Income -15M-16.52M-19.03M-19.56M-20.36M-23.19M-24.78M-16.24M
Net Income -15.02M-16.52M-19.03M-19.56M-20.41M-23.19M-24.78M-16.24M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -15.93M-17.64M-20.34M-21.37M-22.07M-24.62M-26.17M-17.42M
EBITDA -15.83M-17.62M-20.31M-21.34M-22.04M-24.59M-26.14M-17.19M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -3.33M-8.89M-23.02M-53.24M-81.41M
Pre Tax Income -3.33M-9.61M-22.96M-51.49M-75.47M
Net Income -3.33M-9.61M-22.96M-51.51M-75.52M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -13.817-39.551-0.941-2.084-2.729
EBIT -3.33M-8.89M-23.03M-53.32M-81.41M
EBITDA -3.33M-8.89M-23.01M-53.17M-81.31M

Your Recent History

Delayed Upgrade Clock